AngioDynamics Inc (ANGO) - Cumulative Company Assets

Public company logo of AngioDynamics Inc (ANGO)

AngioDynamics, Inc. (ANGO) production of vascular access devices is largely independent of economic cycles and exhibits high resilience to market shocks. The company is currently implementing automated assembly systems with AI control. This price chart of total assets on GURU.Markets clearly demonstrates the changes, showing a value of 253.78, which confirms the development of the brand creating unique NanoKnife tools for the gentle removal of neoplasms in oncology.

AngioDynamics Inc (ANGO) Company Total Assets: for the period 07/04/2022 - 10/28/2026

Comprehensive metric breakdowns and analytics for AngioDynamics Corp (ANGO)

- price and consensus price forecast:
Market Price angiodynamics.com|ANGO - Price Target Chart
- market capitalization data:
Market Valuation AngioDynamics Inc.|ANGO - Enterprise Value
- book capitalization data:
Net Asset Value per Share AngioDynamics|ANGO - Book Capitalization|Capitalization to Book Value Ratio angiodynamics.com|ANGO - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Coefficient AngioDynamics, Inc.|ANGO - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio AngioDynamics Inc.|ANGO - Company Aggregate Debts|Debts to Book Capitalization AngioDynamics Inc.|ANGO - Company Long-Term Debt|Company Short-Term Debt AngioDynamics
Fundamental valuation:angiodynamics.com, ANGO
Manufactured product of AngioDynamics, Inc.

This indicator represents the calculated value of corporate resources, derived inversely through return on assets (ROA). The metric's dynamics are sensitive to operational efficiency, allowing for the determination of business scale prior to the publication of financial statements. Analyzing gross assets helps identify "value trap" risks during a reduction of the asset base. For AngioDynamics, Inc. (ANGO), broad diversification of medical product lines ensures the stability of this base against regulatory changes.

Main competitors

ISRG (intuitive.com) - Company Assets|Aggregate Company Assets DHR|Cumulative Company Assets BD|STERIS Corporation - Company Total Assets|Company Assets West Pharma Corp (WST)|BAX - Company Total Assets|Total Business Assets masimo.com MASI|Company Total Assets STVN (Stevanato Group)|TFX - Company Total Asset Base|MMSI (Merit Medical Systems Inc) - Company Total Assets|Nobel Biocare (NVST) - Cumulative Company Assets|ICUI (ICU Medical, Inc.) - Company Total Assets|Company Total Assets XRAY|Aggregate Company Assets LeMaitre Vascular (LMAT)|Aggregate Company Assets AtriCure Inc ATRC|Cumulative Company Assets STAAR Surgical Corp|Aggregate Asset Value ChromaDex NAGE|Company Total Assets ZIMV (ZimVie Inc.)|CERS: Company Total Asset Base|Aggregate Company Assets Teknova|MGRM (Monogram Technologies Inc.) - Total Business Assets|STSS: Aggregate Company Assets|Company Total Asset Base InfuSystem Inc (INFU)|Cumulative Company Assets Utah Medical Products|Aggregate Business Assets KRMD (korumedical.com)|Aggregate Company Assets Nyxoah|MBOT - Aggregate Asset Value|Pro-Dex Corp - Cumulative Company Assets|ZTEK: Company Total Assets|ELUT (Elutia Inc.) - Aggregate Company Assets|milestonescientific.com (MLSS) - Cumulative Company Assets|Company Total Assets NXGL (NEXGEL)|Company Assets RVP|Aggregate Company Assets Harvard Bioscience HBIO|Total Business Assets Femasys Corporation FEMY|Cumulative Company Assets Meihua Medical Technologies Co., Ltd. (MHUA)|Predictive Oncology Inc - Aggregate Business Assets|Aggregate Company Assets CJMB (Callan JMB Corp)|ATRI - Company Total Asset Base|NURO: Company Total Assets